SCHEMBL8550607

SCHEMBL8550607

Cn1ccnc1C(=O)c1ccccc1N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.50
RAB9A P51151 1/20 0.50
MAPT P10636 3/20 0.46
GAA P10253 2/20 0.46
HSD17B10 Q99714 2/20 0.45
TP53 P04637 1/20 0.45
ALOX15 P16050 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
NAMPT P43490 1/20 0.43
LMNA P02545 4/20 0.42
KMT2A Q03164 4/20 0.42
HTT P42858 2/20 0.42
POLB P06746 1/20 0.42
PRNP P04156 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ALDH1A1 P00352 3/20 0.41
CFTR P13569 1/20 0.41
ESRRA P11474 1/20 0.40
MEN1 O00255 1/20 0.40
LDHA P00338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14818779 0.83 ALDH1A1 (0.50) TSHRRAB9AMAPTTP53SMN1; SMN2
SCHEMBL342698 0.82 CCR9 (0.53) TSHRRAB9AMAPTGAAHSD17B10
SCHEMBL14803848 0.79 TSHR (0.45) TSHRRAB9AMAPTGAASMN1; SMN2
SCHEMBL5604635 0.77 TSHR (0.49) TSHRRAB9AMAPTGAASMN1; SMN2
SCHEMBL1045991 0.77 SMN1; SMN2 (0.58) TSHRRAB9AMAPTGAASMN1; SMN2
Bromide SCHEMBL7373319 0.75 RAB9A (0.48) TSHRRAB9AMAPTGAASMN1; SMN2
SCHEMBL7076440 0.75 MAPK14 (0.61) TSHRRAB9A
SCHEMBL14355876 0.75 ALDH1A1 (0.45) TSHRRAB9AGAASMN1; SMN2LMNA
SCHEMBL7076703 0.74 HTT (0.45) TSHRRAB9AMAPTGAAHSD17B10
SCHEMBL14356009 0.73 ADRB1 (0.42) TSHRRAB9ALMNAKMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0715624-B1 PROCESS FOR THE PREPARATION OF BENZODIAZEPINE COMPOUNDS USEFUL AS ANTAGONISTS OF CCK OR OF GASTRINE YAMANOUCHI PHARMA CO LTD (JP) 1998-04-08 EP disclosed
US-5728829-A MULTISTAGE REACTION OF N-PROTECTED BENZOTRIAZOLYL GLYCINE DERIVATIVE WITH AMINOKETONE, THEN REACTION WITH AMMONIA AND ACID CATALYZED CYCLIZATION FERRING-RESEARCH LIMITED (GB) 1998-03-17 US disclosed
EP-0715624-A1 PROCESS FOR THE PREPARATION OF BENZODIAZEPINE COMPOUNDS USEFUL AS ANTAGONISTS OF CCK OR OF GASTRINE YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1996-06-12 EP disclosed
WO-1995006040-A1 BENZODIAZEPINE COMPOUNDS USEFUL AS ANTAGONISTS OF CCK OR OF GASTRINE YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1995-03-02 WO disclosed
EP-0595980-A1 BENZODIAZEPINE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY MERCK SHARP & DOHME LTD. (GB) 1994-05-11 EP disclosed
WO-1993002078-A1 BENZODIAZEPINE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY MERCK SHARP & DOHME LIMITED (GB) 1993-02-04 WO disclosed